Communication to recommend reviewing the IFU and ensuring that all treatment preparation and handling steps are performed as instructed.
Source facts
Action
On July 30, 2026 IMPORTANT MEDICAL DEVICE INFORMATION letters were sent to customers. Letter provides information and instructions on the use of the device. As part of routine best practice, we recommend reviewing the IFU and ensuring that all treatment
preparation and handling steps are performed as instructed. There are potential risks to patient health that are associated with blood loss, treatment
delay, or air entering the system. Ensure all steps of the IFU are followed, that the
Transducer Protector connection to the bloodline monitor line is tight, and that the
transducer protector and female luer connections are finger tight to maintain a closed
system.
Please contact FMCRTG Technical Service at 1-800-227-2572 if you have any further
questions. For any clinical or medical questions, please contact the Global Medical
Information and Education Office at 1-855-616-2309.
Initiated
2026-07-29
Root cause
Use error
Distribution
Domestic: Nationwide Distribution;
Recall number
Z-3225-2026
Recall status
Open, Classified
CDRH record ID
222235
FDA classified
2026-09-18
Recall event number
99700
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.